Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-111281

General Counsel and Secretary sold 3,450 shares at $48.26 ($166,497)

  • General Counsel and Secretary acquired 6,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-14 Exercise or conversion : show line 1 in the form +6,875 94,690 D
2026-03-16 Sale : show line 2 in the form −3,450 $48.26 $166,497 91,240 D
Open-market sales · 3,450 sh · avg $48.26 · $166,497

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,875 20,625 D
Loading xslF345X05/ownership.xml…